Journal of Tissue Engineering · Nov 12, 2026
A scaffold-free rotary culture system enables scalable production of functionally convergent perinatal MSC spheroids with enhanced pro-regenerative potency
By Li W, Yuan M, Li Q et al.
Mesenchymal stromal cell spheroids (MSC sp ) represent promising bioactive constructs for regenerative medicine; however, scalable scaffold-free approaches for generating functionally enhanced and consistent MSC sp across different tissue sources remain limited. Here, we evaluated a rotary cell culture system (RCCS)-based dynamic 3D platform for scalable MSC sp generation using MSCs derived from amniotic membrane, umbilical cord, and fetal placenta. RCCS-MSC sp harvested at day 2 exhibited compact morphology, uniform size, high viability, and improved mitochondrial function. Compared with monolayer MSCs and hanging drop spheroids, RCCS-MSC sp displayed reduced apoptosis, enhanced antioxidative capacity, and increased extracellular matrix deposition. Transcriptomic analysis revealed conserved activation of immunoregulatory, angiogenic, extracellular matrix, and tissue repair programs across MSC sources. Functionally, RCCS-MSC sp promoted endothelial protection, macrophage polarization, and diabetic wound repair through enhanced vascularization and tissue remodeling. Moreover, RCCS-mediated spheroid formation partially reduced source-associated functional variability among perinatal MSCs. This study provides a scalable scaffold-free 3D bioengineering strategy to generate standardized, functionally enhanced MSC spheroids for translational regenerative applications.